Kirk Habegger, Ph.D., Professor of Medicine in the UAB Department of Medicine Division of Endocrinology, Diabetes and Metabolism, has received funding from Eli Lilly and Company to continue investigation of glucagon receptor activation in incretin-based obesity therapies.

UAB diabetes researchers presented their latest work on an international stage at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria, Sept. 15-19.

Ben Gran is the lab manager for both Dr. Rita Basu and Dr. Ananda Basu who are clinical diabetes researchers at the UCDC. Gran has been with the Basu Lab for a decade supporting cutting-edge diabetes research studies. 

Health care providers from across the state and region gathered to learn about diabetes, thyroid disorders, osteoporosis, and more at the 2025 UAB Endocrinology Update, Aug. 23, at Hilton Birmingham Downtown at the University of Alabama at Birmingham (UAB).

Amy Warriner, M.D., professor in the Department of Medicine, has been named the 2025 recipient of the Brewer-Heslin Award for Professionalism in Medicine.

According to the 2025-2026 rankings released in July, UAB Medicine ranked nationally in five adult specialties and high performing in seven other specialties including diabetes and endocrinology.

A new study led by UAB Comprehensive Diabetes Center Associate Scientist Fernando Bril, M.D., provides the first evidence that MASLD prevalence is beginning to decrease in adults with diabetes in the U.S. for the first time in decades. However, this good news is overshadowed by the significant increase observed in liver fibrosis.

The University of Alabama at Birmingham startup TIXiMED, Inc., has successfully completed a Phase 1 single ascending dose study of the drug TIX100 in humans, marking a key milestone in the development of a first-of-its kind oral therapy for Type 1 diabetes (T1D).

UAB Comprehensive Diabetes Center (UCDC) researchers have contributed to the Frontiers in Endocrinology Research Topic on Disease-Modifying Approaches in Type 1 Diabetes.

Ananda Basu, MBBS, MD, FRCP, M.D., has been appointed as an associate director of the UAB Comprehensive Diabetes Center (UCDC) and will play an integral role on the center’s leadership team.

Researchers from the University of Alabama at Birmingham Comprehensive Diabetes Center (UCDC) showcased their latest findings at the 17th Annual Midwest Islet Club (MIC) Meeting, May 7-8, in Indianapolis, Indiana.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing tools for further exploration into pancreatic alpha cell function in both Type 1 and 2 diabetes and other metabolic disorders.

University of Alabama at Birmingham (UAB) senior Nic Amison recently spent two semesters serving as the UAB Comprehensive Diabetes Center’s (UCDC) first communications intern. 

UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., was invited to write a mini-review for Endocrinology, the flagship journal of the Endocrine Society.

Originally from Elkmont, Alabama, Perez contributes to multiple projects in the Bhatnagar Lab, which researches insulin secretion from beta cells.

UAB Comprehensive Diabetes Center (UCDC) senior scientists Ananda Basu, M.D., and Rita Basu, M.D., were each honored during the UAB Marnix E. Heersink School of Medicine Spring 2025 Endowed Chairs and Professorships Reception, May 7.

UAB Comprehensive Diabetes Center (UCDC) researchers joined experts from around the United States to present current topics related to diabetes at the 16th Annual Boshell Research Day on April 4.

UAB Comprehensive Diabetes Center (UCDC) scientist Kirk Habegger, Ph.D., is featured in the Diabetes Spotlight in the May 2025 issue of Diabetes, the flagship research publication of the American Diabetes Association (ADA). 

Two UAB Comprehensive Diabetes Center (UCDC) members are winners of the 2025 Dean's Excellence Awards for Faculty from the UAB Heersink School of Medicine.